Liminatus Pharma, Inc. (LIMN) News
Follow Liminatus Pharma, Inc. (LIMN) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 16 public stories across 9 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Liminatus Pharma Agrees to Sell 260,001 Shares in $650,002.50 Private Placement
EQUITY | Nov 03, 2026, 09:49 PM UTC
L
Liminatus Pharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard
On September 24, 2026, Nasdaq notified the company that it had regained compliance with the Nasdaq Capital Market minimum bid price rule after a 1-for-50 reverse split and a transfer to the Nasdaq Capital Market on Augus
NEWS | Sep 29, 2026, 01:23 PM UTC
L
Liminatus Pharma, Inc. (LIMN) Regains Nasdaq Bid-Price Compliance After 1-for-50 Reverse Split
Liminatus Pharma, Inc. regained compliance with Nasdaq’s minimum bid price rule after effecting a 1-for-50 reverse stock split on Aug. 20, 2026. Nasdaq confirmed the bid stayed above $1 for 13 consecutive trading days en
EQUITY | Sep 29, 2026, 01:01 PM UTC
L
Liminatus Pharma Regains Compliance with Nasdaq Minimum Bid Price Rule
FULLERTON, Calif., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. NASDAQ:LIMN (“Liminatus” or the “Company”) today announced that the Company has regained compliance with Nasdaq’s minimum bid price rule.As pre
NEWS | Sep 29, 2026, 01:01 PM UTC
L
Multiple stocks execute reverse splits on Friday Aug 21
BTOG, ELAB, SMTK, SCNI, LIMN and XCH are listed for reverse stock splits ranging from 1-for-5 to 1-for-50 on Friday Aug. 21.
EQUITY | Aug 21, 2026, 09:03 AM UTC
M
Multiple stocks schedule reverse splits for Friday Aug. 21
TradeXchange Newsdesk lists reverse stock splits for BTOG 1-for-5, ELAB 1-for-10, SMTK 1-for-50, SCNI 1-for-10, LIMN 1-for-50, XCH 1-for-20 and MGN 1-for-40 on Friday Aug. 21.
EQUITY | Aug 20, 2026, 08:41 PM UTC
M
Multiple companies announce reverse stock splits for Friday Aug. 21
BTOG, ELAB, SMTK, SCNI, LIMN and XCH are listed for reverse stock splits on Friday Aug. 21, with ratios ranging from 1-for-5 to 1-for-50.
EQUITY | Aug 20, 2026, 07:46 PM UTC
H
Liminal Biosciences announces 1-for-50 reverse stock split (8/21)
Liminal Biosciences (LIMN) will execute a 1-for-50 reverse stock split on 8/21, according to TradeXchange Newsdesk.
REGULATION | Aug 18, 2026, 08:03 PM UTC
M
Liminatus Pharma (LIMN) announces reverse stock split
Liminatus Pharma, Inc. (LIMN) announces a reverse stock split of its common stock, according to TradeXchange Newsdesk.
REGULATION | Aug 18, 2026, 08:01 PM UTC
M
Liminatus Pharma transfers to Nasdaq Capital Market, gets bid-price extension
Liminatus Pharma (LIMN) announces its transfer to the Nasdaq Capital Market and an extension aimed at regaining compliance with the Nasdaq minimum bid price requirement.
REGULATION | Aug 13, 2026, 11:15 AM UTC
H
Dow Gains Over 250 Points; US Jobs Rise By 57,000 In June
U.S. stocks traded higher this morning, with the Dow Jones index gaining over 250 points on Thursday. Following the market opening Thursday, the Dow traded up 0.47% to 52,553.59 while the NASDAQ rose 0.32% to 26,124.28.
MACRO | Jul 02, 2026, 01:50 PM UTC
H
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Liminatus Pharma (NASDAQ: LIMN ) stock increased by 40.9% to $0.16 during Thursday's pre-market session. The market value of their outstanding shares is at $5.8 million. Stablecoin Development (AMEX: SDEV ) stock
EARNINGS | Jul 02, 2026, 12:05 PM UTC
H
Why SurgePays Shares Are Trading Higher By 59%; Here Are 20 Stocks Moving Premarket
Shares of Surgepays Inc (NASDAQ: SURG ) rose sharply in pre-market trading after the Tennessee-based wireless and fintech company amended its agreement with a Tier 1 wholesale wireless network provider. The deal restruct
RATES | Jul 02, 2026, 09:32 AM UTC
H
Liminatus Pharma (LIMN) Stock Is Trending Overnight — Here’s Why it Spiked Over 30% in After-Hours Session
Liminatus Pharma, Inc. (NASDAQ: LIMN ) shares are trending on Wednesday night. Shares of the California-based immuno-oncology biotechnology company jumped 30.49% to $0.15 in after-hours trading after Liminatus amended an
MNA | Jul 02, 2026, 04:05 AM UTC
H
Liminatus Pharma shares are trading lower. The company announced it amended its proposed $320 merger deal with InnocsAI.
Liminatus Pharma shares are trading lower. The company announced it amended its proposed $320 merger deal with InnocsAI.
MNA | Jul 01, 2026, 01:21 PM UTC
H
Liminatus Pharma Amends Proposed $320M Merger Deal With InnocsAI As Closing Now Anticipated Before Shareholder Approval On July 2
Liminatus Pharma, Inc. (Nasdaq: LIMN ) ("Liminatus" or the "Company"), a biotechnology company developing innovative cancer therapies, today announced that it has amended and restated the previously announced definitive
MNA | Jun 30, 2026, 08:32 PM UTC